维普中文期刊产品整合服务
182篇 您的检索式:作者名="Durrington PN"
    题名 作者 年代 出处 被引量
1Paraoxonase and coronary heart disease 显示文摘Mackness MI Mackness B Durrington PN 1998Curr Opin Lipidol1998,9,4:1
2Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atonrastatin Diabetes Study (CARDS):multicentre randomised placebo-controlled tral显示文摘Colloun HM Bettendge DJ Durrington PN 2004Lancet2004,364,9435:1
3Paraoxonase and coronary heart disease 显示文摘Mackenss MI Mackmess B Durrington PN 1998Curr Opin Lipidol1998,9,:1
4Paraoxonase and coronary heart disease 显示文摘Mackness MI Mackness B Durrington PN 2002Atheroscler Suppl2002,3,4:1
5Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) : multicenter randomised placebo-controlled trial显示文摘Colhoun HM Betteridge DJ Durrington PN 2004Lancet2004,364,:1
6Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein显示文摘Mackness MI Arrol S Durrington PN 1991FEBS Lett1991,286,:1
7Hydrolysis of platelet-activating factor by human serum paraoxonase 显示文摘Rodrigo L Mackness B Durrington PN 2001Biochem J2001,354,1:1
8Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study ( CARDS ) 显示文摘Colhoun HM Betteridge DJ Durrington PN 2009Am J Kidney Dis2009,54,5:1
9Hyperlipidemia and renal disease 显示文摘Short CD Durrington PN 1990Bail- lieres Clin Endocrinol Metab1990,4,4:1
10Paraoxonase activity in two healthy populations with differing rates of coronary heart disease显示文摘Mackness B Mackness MI Durrington PN 2000Eur J Clin Invest2000,30,1:1
11Primary prevention of cardiovascular disease with atorvastatin in type2diabetes in the Collaborative Atorvastatin Diabetes Study(CARDS):multicentre randomised placebo-controlled trial显示文摘Colhoun HM Betteridge DJ Durrington PN 2004Lancet2004,364,9435:1
12Paraoxonase and coronary heart disease显示文摘 Mackness B Durrington PN 1998Curr Opin Lipidol1998,9,:1
13Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study(CARDS):multicentre randomised placebo-controlled trial显示文摘Colhoun HM Betteridge DJ Durrington PN 2004Lancet2004,364,:1
14Paraoxonase and atherosclerosis 显示文摘Durrington PN Mackness B Mackness MI 2001Arterioscler Thromb Vasc Biol2001,21,4:1
15Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicenlre randomized placebo controlled trial 显示文摘Colhoun HM Bettemdge D J Durrington PN 2004Lancet2004,364,9435:1
16Semiau- tomated method for determination of serum paraoxonase activity using paraoxon as substrate 显示文摘Charhon-Menys V Liu Y Durrington PN 2006Clin Chem2006,52,3:1
17Paraoxonase and coronary heart disease显示文摘Mackness MH Mackness B Durrington PN 1998Curr Opin Lipidol1998,9,4:1
18Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):Multicentre randomised placebo-controlled trial显示文摘Colhoun HM Betteridge DJ Durrington PN 2004Lancet2004,364,:1
19Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study(CARDS) : multicentre randomised placebocontrolled trial显示文摘Colhoun HM Betteridge D J Durrington PN 2004Lancet2004,364,21:1
20Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):multicentre randomised placebo-controlled trial显示文摘Colhoun HM Betteridge DJ Durrington PN 0,,21:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费